Ragupathy Madiyalakan

Ragupathy Madiyalakan discloses dealings in Quest PharmaTech Inc. to SEDI. We count 12 filings; the first trade dates from 17 June 2004 and the latest from 21 July 2025.

Purchases make up the whole of the open-market record (4 purchases, €3,510). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 option exercises.

The median purchase comes to €849. No cluster: in 3 purchases, no other insider of the company bought within 30 days.

The record was last updated on 23 July 2025 with a transaction (€25k) in Quest PharmaTech Inc. The most recent open-market purchase was published on 18 September 2023, 1,132 days ago. The median gap between a trade and its publication by SEDI is 2 days. The shorter that gap, the sooner other investors can see what insiders have done. Source: insider filings from SEDI. Past trades are no guide to future returns.